Summary:
- Kenyan health authorities have announced that they will start providing a new HIV prevention drug called Cabotegravir for free to the public.
- This injectable drug has been shown to be more effective than the current oral PrEP (pre-exposure prophylaxis) medication in preventing HIV transmission.
- The availability of this new drug is expected to significantly contribute to Kenya's efforts to control the HIV/AIDS epidemic and reduce new infections, especially among high-risk populations.